Drug intelligence / Profile preview

ascaris suum extract

Development stage
Unknown
Modality
Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Intradermal, Inhalation, Topical
01

Overview

Ascaris suum extract is a biological preparation derived from the parasitic nematode *Ascaris suum* (the large roundworm of pigs). It is primarily utilized in clinical and preclinical research as a potent allergen challenge agent to model and study Type I hypersensitivity reactions. In animal models, including cynomolgus monkeys, dogs, and pigs, the extract is administered via intradermal injection or aerosolized inhalation to induce early-phase (EPR) and late-phase (LPR) allergic responses. These responses are characterized by mast cell degranulation, wheal-and-flare formation, and subsequent inflammatory cell infiltration (eosinophils and mononuclear cells). The extract is a standard tool for evaluating the efficacy of novel anti-inflammatory and anti-allergic therapeutics for conditions such as asthma and atopic dermatitis.

Other names
Ascaris suum allergenAscaris suum antigenAscaris suum extract
02

Targets

IgE (Immunoglobulin E)

Beyond the preview

Go deeper on ascaris suum extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ascaris suum extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call